Research - Edinburgh, Scotland, United Kingdom
Avipero Ltd is a private biotech stablished in 2009 based in Edinburgh. Avipero is developing allosteric modulators of integrins for Triple Negative Breast Cancer (TNBC). Avipero is led by strong team with track record in drug development and cancer.
Rackspace Email
Microsoft-IIS